With the analysis among 558 patents, we discovered top 63 key players by total patent application. Eli Lilly & Co., Intra-Cellular Therapies, Inc., Astellas Pharma, Inc. are dominant in this area. They take 26.88% of the total patent filing.
Indiana, United States
Patent: 65
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 45
Tokyo-to, Japan
Patent: 40
Antwerpen, Belgium
Patent: 24
Maharashtra, India
Patent: 23
California, United States
Patent: 22
Hessen, Germany
Patent: 17
Hertfordshire, United Kingdom
Patent: 16
F. Hoffmann-La Roche Ltd.
Pharmacia & Upjohn Co. LLC
Michigan, United States
Patent: 13
No data, please try another search term
With the analysis among related 12 patents applied in the last 5 years. We discover 6 most active companies in this area. The fast-growing Intra-Cellular Therapies, Inc., Abbott GmbH (Germany), AbbVie, Inc. take 91.67% of patent filing during this period.
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 6
Illinois, United States
Patent: 2
Korea Advanced Institute of Science & Technology
Korea Institute of Science & Technology
Xoc Pharmaceuticals, Inc.
California, United States
Patent: 1
No data, please try another search term
With the analysis among 50 patents, we discovered top 12 universities and scientific research institutions by total patent application. Virginia Commonwealth University, Korea Institute of Science & Technology, University of Bari are dominant in this area. They take 54.00% of the total patent filing.
Virginia Commonwealth University
Virginia, United States
Patent: 11
Korea Institute of Science & Technology
Xinxiang Medical University
Henan Sheng, China
Patent: 2
Korea Advanced Institute of Science & Technology
Shanghai Shi, China
Patent: 1
Federal University of Rio de Janeiro
Rio de Janeiro, Brazil
Patent: 1